(Q34696896)

4 August 2017

title

Cardiac toxicity of daunorubicin. (English)

1 reference

4 August 2017

0 references

1 reference

G Bonadonna

1

1 reference

4 August 2017

S Monfardini

series ordinal

2

1 reference

4 August 2017

language of work or name

English

0 references

publication date

1 April 1969

1 reference

4 August 2017

1 reference

4 August 2017

volume

1

1 reference

4 August 2017

issue

7599

1 reference

4 August 2017

page(s)

837

1 reference

Daunomycin, an antitumor antibiotic, in the treatment of neoplastic disease. Clinical evaluation with special reference to childhood leukemia

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2869%2992093-5

7 January 2021

Rubidomycin in Acute Leukaemia in Adults

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2869%2992093-5

7 January 2021

Daunorubicin in acute myelocytic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2869%2992093-5

7 January 2021

Daunomycin Treatment in Chronic Lymphoproliferative Disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2869%2992093-5

7 January 2021

Acute lymphoblastic leukaemia treated with a combination of prednisone, vincristine, and rubidomycin. Value of pathogen-free rooms

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2869%2992093-5

7 January 2021

A demonstration that the risk of postoperative deep venous thrombosis is reduced by stimulating the calf muscles electrically during the operation.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2869%2992093-5

7 January 2021

Blood-flow in deep veins of leg: Recording technique and evaluation of methods to increase flow during operation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2869%2992093-5

7 January 2021

10.1016/S0140-6736(69)92093-5

Identifiers

DOI

1 reference

4 August 2017

1 reference